Farmax India Limited reported unaudited standalone earnings results for the first quarter ended June 30, 2014. For the quarter, the standalone company reported total income from operations of INR 31.979 million against INR 37.488 million a year ago. Loss from operations before other income and exceptional items was INR 24.493 million against INR 25.171 million a year ago.

Loss from ordinary activities before tax was INR 23.914 million against INR 24.489 million a year ago. Net loss for the period was INR 23.914 million or INR 0.06 per basic and diluted share after extraordinary items against INR 24.489 million or INR 0.06 per basic and diluted share after extraordinary items a year ago.